|
|
|
Volumn 105, Issue , 1999, Pages 16-24
|
|
Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SEROTONIN AGONIST;
SUMATRIPTAN;
VASOCONSTRICTOR AGENT;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MIGRAINE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PATIENT SATISFACTION;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
TREATMENT OUTCOME;
ACUTE DISEASE;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
PATIENT SATISFACTION;
RECURRENCE;
SEROTONIN AGONISTS;
SUMATRIPTAN;
TREATMENT OUTCOME;
VASOCONSTRICTOR AGENTS;
|
|
EID: 0033169971
PISSN: 1368504X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
